6-K ·Filed Sep 1, 2026

GSK

GSK plc
NEUTRAL
Impact 1/10
Horizonimmediate Processed1mo ago SEC0001654954-26-008044
Actionable Insight • Neutral

No actionable trading signal. This is a routine voting rights notification with no impact on fundamentals, guidance, or capital structure. Monitor next earnings release or material event for directional cues.

DirectionNeutral
Confidencehigh
Horizonimmediate
Latest settled — T+20d ⚠ clustered
GSK ▼ -3.93% at T+20d
NEUTRAL call ✗ call lost -3.93% · α vs SPY -5.11% · entry $50.66 → $48.67
Next anchor: T+60d in 8w
Entry anchored
Sep 1, 12:26 PM ET
via 1-min bar
T+1d
-0.43%
call -0.43% · α -0.88%
$50.44
settled 4w ago
T+5d
-4.01%
call -4.01% · α -4.09%
$48.63
settled 23d ago
T+20d
-3.93%
call -3.93% · α -5.11%
$48.67
settled 2d ago
T+60d
—
call — · α —
—
in 8w

Price Chart

Loading chart...

Executive Summary

GSK filed a routine Total Voting Rights notification under UK Disclosure Guidance and Transparency Rule 5.6.1R, disclosing its issued share capital as of 31 August 2026. The filing confirms 4,316,302,379 ordinary shares outstanding, with 270,881,064 held in treasury, resulting in 4,045,421,315 voting rights. This is a standard administrative disclosure with no material financial or operational impact.

Key Facts

  • Issued share capital as of 31 August 2026: 4,316,302,379 ordinary shares of 31.25 pence each.
  • Treasury shares: 270,881,064.
  • Total voting rights: 4,045,421,315.
  • Filing is a routine monthly disclosure under FCA DTR 5.6.1R.

Financial Impact

No financial impact — routine administrative disclosure.

Risk Factors

  • No material risks identified from this filing.

Market Snapshot

Exchange
OTC
Sector
Pharmaceutical Preparations
Analyst Consensus
44% bullish (32 analysts)

Investment Themes

Biotech & Drug Discovery

Documents Analyzed

This report is based on 8 SEC documents filed with EDGAR.

DocumentAccession Number
6-K Filing (GSK) — Batch item 10001654954-26-008044
Document: 0001654954-26-008044-index-headers.html0001654954-26-008044
Document: 0001654954-26-008044-index.html0001654954-26-008044
Document: 0001654954-26-008044.txt0001654954-26-008044
6-K Filing (GSK) — Batch item 50001654954-26-008044
Document: 0001654954-26-008044-index-headers.html0001654954-26-008044
Document: 0001654954-26-008044-index.html0001654954-26-008044
Document: 0001654954-26-008044.txt0001654954-26-008044
42 reports for GSK
Performance horizon
69% Hit rate 11 of 16 directional calls best @ T+60▲ +7.85%Jun 16, 2026
Filters
Rows
Reports for GSK — sortable, filterable
TypeNow
Sep 15, 2026
17d ago
6-K
NEUTRAL ★ 5/10
$50.01 $50.22▲ +0.42%▼ −0.40%$47.03 (−5.96%)
Sep 14, 2026
18d ago
6-K
BULLISH ★ 7/10
$50.05 $51.08▲ +2.06%▲ +1.95%$47.03 (−6.03%)
Sep 14, 2026
18d ago
6-K
BULLISH ★ 7/10
$50.05 $51.08▲ +2.06%▲ +1.95%$47.03 (−6.03%)
Sep 11, 2026
21d ago
6-K
NEUTRAL ★ 1/10
$48.13 $50.22▲ +4.34%▲ +4.56%$47.03 (−2.29%)
Sep 10, 2026
22d ago
6-K
NEUTRAL ★ 1/10
$48.12 $51.06▲ +6.11%▲ +6.61%$47.03 (−2.27%)
Sep 10, 2026
22d ago
6-K
NEUTRAL ★ 3/10
$48.12 $51.06▲ +6.11%▲ +6.61%$47.03 (−2.27%)
Sep 1, 2026
4w ago
6-K
NEUTRAL ★ 1/10
$50.66 $48.63▼ −4.01%▼ −4.09%$47.03 (−7.17%)
Sep 1, 2026
4w ago
6-K
BULLISH ★ 6/10
$50.66 $48.63▼ −4.01%▼ −4.09%$47.03 (−7.17%)
Aug 26, 2026
5w ago
6-K
NEUTRAL ★ 1/10
$51.43 $50.44▼ −1.92%▼ −1.80%$47.03 (−8.56%)
Aug 24, 2026
5w ago
6-K
NEUTRAL ★ 2/10
$51.78 $50.25▼ −2.95%▼ −3.42%$47.03 (−9.17%)
Showing 10 of 42

US Market Status

Market Closed — Opens Mon (65h 4m)

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access